<DOC>
	<DOCNO>NCT02347917</DOCNO>
	<brief_summary>This open-label , multicenter , phase 1/2 study BBI608 combination pemetrexed cisplatin chemotherapy 1st line treatment Malignant Pleural Mesothelioma ( MPM ) .</brief_summary>
	<brief_title>A Study BBI608 Combination With Pemetrexed Cisplatin Adult Patients With Malignant Pleural Mesothelioma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Phase 1 Histologically confirm diagnosis Malignant Pleural Mesothelioma ( MPM ) NonSmall Cell Lung Cancer ( NSCLC ) . Measurable disease define modify Response Evaluation Criteria Solid Tumors ( mRECIST ) MPM RECIST 1.1 NSCLC . ≥ 20 year age . Provision write informed consent . For male female patient child produce potential : Must agree use contraception take measure avoid pregnancy study 30 day last protocol treatment dose . Eastern Cooperative Oncology Group ( ECOG ) Performance Status 0 1 . Hemoglobin ( Hb ) ≥ 9.0 g/dL . Neutrophils ≥ 1500/μL . Platelets ≥ 100,000/μL . Aspartate transaminase ( AST ) alanine transaminase ( ALT ) ≤ 2.5fold upper limit normal range ( ULN ) [ ≤ 5fold ULN liver metastasis ] . Total bilirubin ≤ 1.5fold ULN . Creatinine clearance ( estimate value ) ≥ 60 mL/min . Life expectancy ≥ 3 month . Females childbearing potential negative urine pregnancy test . Phase 2 Histologically confirm diagnosis MPM . Treatment naïve indicate resection . Measurable disease define modified RECIST . ≥ 20 year age . Provision write informed consent . For male female patient child produce potential : Must agree use contraception take measure avoid pregnancy study 30 day last protocol treatment dose . ECOG Performance Status 0 1 . Hb ≥ 9.0 g/dL . Neutrophils ≥ 1500/μL . Platelets ≥ 100,000/μL . AST ALT ≤ 2.5fold ULN [ ≤ 5fold ULN patient liver metastasis ] . Total bilirubin ≤ 1.5fold ULN . Creatinine clearance ( estimate value ) &gt; 60 mL/min . Life expectancy ≥ 3 month . Females childbearing potential negative urine pregnancy test . Both Phase 1 2 Prior anticancer chemotherapy radiotherapy . Prior hormonal therapy , immunotherapy , thermotherapy , operation . Any brain metastasis require treatment symptomatic . Active multiple primary cancer . Crohn 's disease , ulcerative colitis , small intestine resection . Abnormal ECGs . Prior myocardial infarction . Current use antiarrhythmic medication . Uncontrolled concurrent disease . Known severe hypersensitivity pemetrexed , cisplatin drug contain platinum . Women pregnant breastfeeding . Received investigational drug . Unable unwilling swallow BBI608 capsule daily . Prior treatment BBI608 . Ineligible participation study opinion Investigators .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>